|Articles|August 27, 2019
Containing Cytotoxic Product during Transport
Author(s)Flow Sciences, Inc.
The purpose of this document is to serve as a case study where a containment device was designed to facilitate “interim containment”, or containment during the portion of a process where the product isn’t inside the enclosure.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Trending on Pharmaceutical Technology
1
Rare Disease Treatments: Navigating the Economics of Global Innovation
2
Women in STEM: Early Phase Drug Development
3
Drug Digest: Outsourcing Partnerships Fuel Global Biopharma Discovery and Scale-Up
4
PharmTech Weekly Roundup - February 6, 2026
5